ReviewCurrent opinion in biotechnology2022

Innovative nonviral gene delivery strategies for engineering human mesenchymal stem cell phenotypes toward clinical applications.

Andrew Hamann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.